Target intelligence / Profile preview

novel transcript antisense to a novel protein (ENSG00000261293)

Target
ENSG00000261293
Molecular classification
Long non-coding RNA (lncRNA), Antisense transcript
01

Overview

ENSG00000261293 is annotated as a "novel transcript, antisense to a novel protein," indicating it is a predicted long non-coding RNA (lncRNA) gene that overlaps a region coding for a putative or uncharacterized protein, transcribed from the opposite strand. Antisense lncRNAs can regulate the expression of neighboring or overlapping protein-coding genes through a variety of mechanisms, including chromatin modification, transcriptional interference, and mRNA stability regulation. However, there is no direct evidence supporting this gene as a protein, enzyme, receptor, or established therapeutic target, nor is there pathway, marker, or drug interaction information available. This entry is typical for many systematic non-coding transcript annotations produced by genomic projects where biological roles remain unvalidated. This target does not fit the classical definitions of therapeutic targets and serves primarily as a reference for ongoing genomic annotation projects.

Other names
ENSG00000261293novel transcript antisense to a novel protein
02

Biological functions

Gene expression regulation (inferred general function of antisense lncRNAs)
03

Disease associations

Other (Antisense lncRNAs can play roles in disease but specific disease associations for ENSG00000261293 are unreported)

Beyond the preview

Go deeper on novel transcript antisense to a novel protein (ENSG00000261293).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript antisense to a novel protein (ENSG00000261293).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call